Dr Maricris Enriquez Lapinid, MD | |
1201 W Agency Rd, West Burlington, IA 52655-1645 | |
(570) 867-1441 | |
Not Available |
Full Name | Dr Maricris Enriquez Lapinid |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 18 Years |
Location | 1201 W Agency Rd, West Burlington, Iowa |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780998450 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 42257 (Iowa) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
News Archive
Next Dimension Imaging, a leading provider of Medical Education software for the Anatomy of the human body has announced the release of its new product AnatomyLab IV. Based on a new multi-million-polygon 3D-model, the product combines information technology with 3-dimensional anatomical visualization.
Understanding membrane protein crystallization is one of the main goals of molecular biology studies aimed at the structural characterization of proteins.
A wide variety of early-stage, healthcare technology innovation projects in NeuroHealth, Traumatic Stress Disorders, and integrated clinical environments were among those chosen to receive more than $3 million in CIMIT seed grants for FY11.
Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO (teriflunomide) 14 mg as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS).
While marijuana use amongst youth remains stable, youth admission to substance abuse treatment facilities has increased, according to new research from Binghamton University, State University of New York.
› Verified 3 days ago
Entity Name | Kaiser Foundation Health Plan Of The Northwest |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040220000099 |
News Archive
Next Dimension Imaging, a leading provider of Medical Education software for the Anatomy of the human body has announced the release of its new product AnatomyLab IV. Based on a new multi-million-polygon 3D-model, the product combines information technology with 3-dimensional anatomical visualization.
Understanding membrane protein crystallization is one of the main goals of molecular biology studies aimed at the structural characterization of proteins.
A wide variety of early-stage, healthcare technology innovation projects in NeuroHealth, Traumatic Stress Disorders, and integrated clinical environments were among those chosen to receive more than $3 million in CIMIT seed grants for FY11.
Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO (teriflunomide) 14 mg as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS).
While marijuana use amongst youth remains stable, youth admission to substance abuse treatment facilities has increased, according to new research from Binghamton University, State University of New York.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Maricris Enriquez Lapinid, MD 1201 W Agency Rd, West Burlington, IA 52655-1645 Ph: (570) 867-1441 | Dr Maricris Enriquez Lapinid, MD 1201 W Agency Rd, West Burlington, IA 52655-1645 Ph: (570) 867-1441 |
News Archive
Next Dimension Imaging, a leading provider of Medical Education software for the Anatomy of the human body has announced the release of its new product AnatomyLab IV. Based on a new multi-million-polygon 3D-model, the product combines information technology with 3-dimensional anatomical visualization.
Understanding membrane protein crystallization is one of the main goals of molecular biology studies aimed at the structural characterization of proteins.
A wide variety of early-stage, healthcare technology innovation projects in NeuroHealth, Traumatic Stress Disorders, and integrated clinical environments were among those chosen to receive more than $3 million in CIMIT seed grants for FY11.
Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO (teriflunomide) 14 mg as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS).
While marijuana use amongst youth remains stable, youth admission to substance abuse treatment facilities has increased, according to new research from Binghamton University, State University of New York.
› Verified 3 days ago
Dr. Dennis George Miller I, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1706 W Agency Rd, West Burlington, IA 52655 Phone: 319-768-5858 Fax: 319-753-2301 | |
David W Carlson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 W Agency Rd, West Burlington, IA 52655 Phone: 319-754-4242 Fax: 319-754-4079 | |
Michael K Abouassaly, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 W Agency Rd, West Burlington, IA 52655 Phone: 319-754-4242 Fax: 319-754-4079 | |
William S Daft, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 W Agency Rd, West Burlington, IA 52655 Phone: 319-754-4242 Fax: 319-754-4079 | |
Dr. Anjali Katiyar Sobti, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 W Agency Rd, West Burlington, IA 52655 Phone: 319-754-4242 | |
Thomas C Boyd, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1201 W Agency Rd, West Burlington, IA 52655 Phone: 319-754-4242 Fax: 319-754-4709 | |
Jennifer Bagwell De La Rosa, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 W Agency Rd, West Burlington, IA 52655 Phone: 319-754-4242 Fax: 319-754-4079 |